New research demonstrates that cancer stem cells or “tumor-initiating cells,” when targeted with a reprogrammed herpes virus, can be prevented from turning malignant and re-initiating disease. The finding bolsters the theory that cancer harbors its own secret cache of stem cells that are resistant to conventional therapies and responsible for tumor re-emergence. This type of virus-against-cancer therapy may be the next generation of anti-cancer treatments. The study was published online Jan. 21 in the journal PLoS (Public Library of Science) One.
adaptive immunity Alzheimer's Disease antibiotics apoptosis bacteria Breast cancer C. elegans Caenorhabditis elegans cancer chromatin circadian clocks CRISPR cryo-electron microscopy DNA dopamine Drosophila Epigenetics eukaryotes evolution gene expression Genomics histones HIV HIV AIDS human genome immunity metabolism microRNA miRNA mitochondria mRNA neural circuits neurodegeneration neurons obesity optogenetics Parkinson's Disease pathogenesis proteomics ribosomes RNA stem cells synapses transcription vaccines